The FDA has officially withdrawn approval for the pregnancy drug Makena, based on postmarketing studies which failed to show it provided any benefits to pregnant mothers.
The makers of the controversial pregnancy drug, Makena, have decided to withdraw the medication from the market after health experts determined it provides no benefit to pregnant women or their…
Health experts say problems with the accelerated drug approval program have led to Makena and other ineffective drugs staying on the market even after its proven they do not work.
A product liability lawsuit against both Abbott and Mead Johnson claims feeding a premature infant Similac and Enfamil led to long-term NEC complications.
A mother has filed a wrongful death lawsuit against the makers of Similac and Enfamil infant formula, claiming both of her newborn twins contracted necrotizing enterocolitis after consuming them, resulting…
A Colorado mother says feeding her premature son Similac and Enfamil resulted in a fatal case of necrotizing enterocolitis.
The FDA will hold a hearing later this year to determine whether Makena should be removed from the market because the pregnancy drug's risks appear to outweigh its benefits.
A new study links gestational age with the odds of survival in premature infants, but also warns that certain ailments, such as respiratory failure and necrotizing enterocolitis, greatly decrease their…
A wrongful death lawsuit filed by the parents of a baby girl who died at only five days old says her fatal case of necrotizing enterocolitis was caused by Similac…
